U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07670195) titled 'BCAAs in Concussion 3.0' on June 19.
Brief Summary: This study is a randomized, placebo-controlled, double-blinded, therapeutic exploratory clinical trial of branched chain amino acids (BCAAs) in the treatment of concussion. The aim of the study is to determine whether administration of high-dose BCAAs compared to placebo promotes concussion recovery.
Study Start Date: July, 2026
Study Type: INTERVENTIONAL
Condition:
Concussion (Diagnosis)
MTBI - Mild Traumatic Brain Injury
Concussion, Brain
Concussion
Intervention:
DRUG: BCAA
The three BCAAs will be combined together into a powder formulation.
OTHER: Placebo
The placebo fo...